Please find attached Capital Change Notices regarding the issue of performance shares for the acquisition of Zalm Therapeutics Ltd as per the Shareholder resolution dated 19 January 2022
Analysts believe the casino operator’s NZICC claim is unlikely to succeed.
That figure feels expensive to one analyst on this side of the Tasman.
A generation of business owners are starting to get "exit ready", Link says.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details